Company intelligence / Profile preview

Vyasa Analytics

Ownership: Private
Development stage: Other

Overview

Vyasa Analytics specializes in highly scalable, AI-powered data analytics platforms for healthcare, life sciences, and enterprise. Its flagship Vyasa Layar platform is a modular data fabric that connects, curates, and analyzes large, disparate datasets (structured, unstructured, images) to empower research, discovery, and decision-making. The company is primarily a technology provider, not a drug developer, and was acquired by Certara in 2023 to enhance Certara’s biosimulation and AI offerings for drug R&D.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Vyasa Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vyasa Analytics.

Explore the full profile